Zoll Medical 12-0242-000 - ResQPOD Impedance Threshold Device (ITD) 10,

Zoll Medical 12-0242-000 - ResQPOD Impedance Threshold Device (ITD) 10,

Zoll Medical 12-0242-000 ResQPOD Impedance Threshold Device (ITD) 10

Impedance Threshold Device (ITD) that attaches to the airway during CPR to enhance negative pressure and increase perfusion. The ITD 10 is a disposable product (one time use only).

The Zoll Medical 12-0242-000 ResQPOD Impedance Threshold Device (ITD) 10 is a medical device designed to enhance blood circulation and improve the effectiveness of CPR during cardiac arrest and other critical care situations. Here's a summary of its key features and functionalities:

Purpose:

• ITD technology helps regulate intrathoracic pressure (the pressure within the chest cavity) during CPR.
• By creating a slight vacuum during chest recoil (the relaxation phase between compressions), it aims to:
  • Increase preload (blood returning to the heart)
  • Reduce intracranial pressure (pressure on the brain)
  • Improve blood flow to vital organs, particularly the brain and heart.

Key features and benefits of the Zoll Medical ResQPOD ITD 10 may include:

• Improved Blood Flow: The device aims to enhance blood flow to the heart and brain during CPR, potentially improving the chances of successful resuscitation.
• Easy Integration: The ResQPOD ITD 10 is designed to be easily integrated into existing CPR protocols and equipment, making it a practical addition for emergency medical providers.
• Compatibility: It is often compatible with various ventilation devices and CPR masks, allowing for versatility in different emergency settings.
• Clinical Evidence: Manufacturers typically provide clinical studies and evidence supporting the effectiveness of the ResQPOD ITD in improving hemodynamics during CPR.
• User-Friendly Design: The device is designed to be user-friendly, with clear instructions for proper application and usage.

Important Notes:

• The ITD 10 is not a substitute for standard CPR practices.
• It should only be used by trained medical professionals familiar with its operation and potential risks.
• While promising, the long-term impact and effectiveness of the ITD 10 are still under investigation.